OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 5

Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review
Rathnam Venkat, Zachary S. Wallace, Jeffrey A. Sparks
Current Rheumatology Reports (2023) Vol. 25, Iss. 11, pp. 236-245
Closed Access | Times Cited: 8

Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study
Rathnam Venkat, Xiaosong Wang, Naomi J. Patel, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 10, pp. 2828-2837
Closed Access | Times Cited: 7

Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
Sara K. Tedeschi, Daniel H. Solomon, Yuezhou Chen, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 59, pp. 152177-152177
Open Access | Times Cited: 5

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors
Sara Bindoli, Chiara Baggio, Paola Galozzi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4741-4741
Open Access | Times Cited: 2

4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients
María José Gallardo, Marcos Cruces, Yolanda M. Gómez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion
Brygida Kwiatkowska, Magdalena Krajewska–Włodarczyk, Bogdan Batko, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 1, pp. 4-17
Open Access

Clinical management in the COVID-19 pandemic: Rheumatic disease
Abdulvahap Kahveci, Şebnem Ataman
Elsevier eBooks (2024), pp. 111-121
Closed Access

Lupus and SARS-CoV-2: What have we learned after the pandemic?
Rachele Francese, Massimo Rittà, David Lembo, et al.
Lupus (2024)
Closed Access

Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases
BS Belov, N. V. Muravyevа, A. N. Kulikov
Antibiot Khimioter = Antibiotics and Chemotherapy (2022) Vol. 67, Iss. 5-6, pp. 70-80
Open Access | Times Cited: 1

Eficacia y seguridad de vacunas contra SARS-CoV-2 en pacientes con enfermedades reumatológicas autoinmunes
Paola Alexandra Cárdenas Maldonado, Karina Fernanda Pucha Aguinsaca, Mariela de los Ángeles Cárdenas Coello
Revista Vive (2023) Vol. 6, Iss. 17, pp. 547-559
Open Access

Page 1

Scroll to top